Zydus Cadila signs collaborative research agreement with CSIR-IMTECH

05 Jul 2018 Evaluate

Zydus Cadila has signed a collaborative research agreement with the Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH), Government of India. The research partnership will primarily aim to identify new drug candidates for treatment of drug-resistant infections.

The agreement between CSIR-IMTECH and the company will see scientists from both organizations working closely together on microbiology & genomics to identify new lead candidate as novel anti-tuberculosis compounds. For this project, scientists at IMTECH will utilize their expertise and scientific knowledge in microbiology, while Zydus Cadila will provide its expertise in medicinal chemistry & pharmaceutical drug development with an aim to develop new drug combinations against drug-resistant pathogens which causes severe diseases in India and across the world.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

879.00 11.20 (1.29%)
19-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1386.00
Zydus Lifesciences 879.00
Lupin 2178.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×